US regulators will begin offering faster reviews to new medicines that administration officials deem as promoting the health interests of Americans, under a new initiative announced Tuesday.

Once a suspect COVID cure, now a right-wing aspirin. As a physician who diagnoses cancer, I have come across this line of ...

Although vaccines may have a tougher time winning the endorsement of the CDC's Advisory Committee on Immunization Practices ...